Achieve Life Sciences, Inc. (NASDAQ:ACHV)
| Market Cap | $697.68M+70.8% |
| Revenue (ttm) | $114.00K |
| Net Income | -$111.71M-113.4% |
| EPS | -$1.38-0.0% |
| Shares Out | 102.90M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,088,136 |
| Open | $6.83 |
| Previous Close | $6.72 |
| Day's Range | $6.52 - $6.91 |
| 52-Week Range | $2.62 - $8.64 |
| Beta | 2.41 |
| Analysts | Buy |
| Price Target | $15.25(+124.93%) |
| Earnings Date | Mar 11, 2027 |
About ACHV
Achieve Life Sciences, Inc. operates as a clinical-stage pharmaceutical firm, concentrating on the development and market introduction of cytisinicline. This compound is aimed at assisting with smoking cessation and nicotine dependence, with commercial activities spanning Canada, the United States, and the United Kingdom. Cytisinicline is a naturally occurring alkaloid, which functions by engaging with nicotine receptors in the brain to lessen the intensity of nicotine withdrawal symptoms. The company holds licensing agreements with Sopharma AD and the University of Bristol. Its corporate headquarters are located in Vancouver, Canada.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Next catalysts
- Mar 11, 2027Earnings report
$ACHV stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in ACHV holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by ACHV's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
ACHV Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New ACHV patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to ACHV from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in ACHV
| VTIVanguard Morningstar Total Stock Market ETF | $13.52M |
| VXFVanguard Extended Market ETF | $6.81M |
| VTWOVanguard Russell 2000 ETF | $3.12M |
| FESMFidelity Enhanced Small Cap ETF | $1.86M |
| VFMOVanguard U.S. Momentum Factor ETF | $1.56M |
| DWASInvesco Dorsey Wright SmallCap Momentum ETF | $1.14M |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from ACHV’s recent data — informational, not investment advice
What’s Behind the Score
News check: Rebranding and Q3 results reporting show business momentum, though earnings details unclear; mixed outlook on market reception.
Recent Insider Activity
Frequently Asked Questions
ETFs that hold this stock
| DWAS | Invesco Dorsey Wright SmallCap Momentum ETF | 0.32% |
| VFMO | Vanguard U.S. Momentum Factor ETF | 0.08% |
| FSEG | Fidelity Enhanced Small Cap Growth ETF | 0.07% |
| VMO.TO | Vanguard Global Momentum Factor ETF | 0.05% |
| VTWG | Vanguard Russell 2000 Growth ETF | 0.04% |
| FESM | Fidelity Enhanced Small Cap ETF | 0.03% |
| LABU | Direxion Daily S&P Biotech Bull 3X Shares | 0.03% |
Weight is the stock’s share of each fund’s holdings.
